Medtronic plc (NYSE: MDT) is expected to release earnings results for its third quarter of fiscal year 2024, before the opening bell on Feb. 20, 2024.
Analysts expect the Dublin, Ireland-based company to report quarterly earnings at $1.26 per share, down from year-ago earnings of $1.3 per share. Medtronic is projected to report quarterly revenue of $7.95 billion, according to data from Benzinga Pro.
The company recently announced CE (Conformité Européenne) Mark approval for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) which does not require a fingerstick or overtape.
Additionally, Medtronic announced that it received FDA approval of its Percept RC Deep Brain Stimulation (DBS) system.
Medtronic shares fell 0.4% to …
Leave a Reply